Gritstone bio, Inc. Common Stock
GRTS
GRTS was delisted on the 21st of October, 2024.
79 hedge funds and large institutions have $24.2M invested in Gritstone bio, Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 14 increasing their positions, 25 reducing their positions, and 33 closing their positions.
674% more call options, than puts
Call options by funds: $1.03M | Put options by funds: $133K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
7% less funds holding
Funds holding: 85 → 79 (-6)
18% less first-time investments, than exits
New positions opened: 27 | Existing positions closed: 33
44% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 25
80% less capital invested
Capital invested by funds: $120M → $24.2M (-$96.2M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
+$2.92M |
| 2 |
AG
Artal Group
Luxembourg
|
+$1.69M |
| 3 |
Millennium Management
New York
|
+$936K |
| 4 |
Goldman Sachs
New York
|
+$577K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$504K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$7.9M |
| 2 |
BlackRock
New York
|
-$4.15M |
| 3 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
-$3.77M |
| 4 |
FLSM
Frazier Life Sciences Management
Palo Alto,
California
|
-$2.65M |
| 5 |
Morgan Stanley
New York
|
-$1.93M |
GRTS Hedge Fund Activity: Q2 2024 in Review
79 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Gritstone bio, Inc. Common Stock (GRTS) for Q2 2024, worth a combined $24.2M — down 80% from $120M a quarter earlier.
Sellers outnumbered buyers: 33 funds closed out of GRTS and 27 opened new positions — a net loss of 6 holders — while 25 trimmed existing stakes and 14 added.
The largest buyer was Alyeska Investment Group, opening a new position worth an estimated $2.92M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $7.9M sold.
- 79 institutional investors held Gritstone bio, Inc. Common Stock (GRTS) as of Q2 2024, down from 85 in Q1 2024.
- Funds reported $24.2M of Gritstone bio, Inc. Common Stock stock for Q2 2024, down 80% quarter-over-quarter.
- 27 funds opened new Gritstone bio, Inc. Common Stock positions in Q2 2024 and 33 closed out, a net change of -6 holders.
- The largest Gritstone bio, Inc. Common Stock buyer in Q2 2024 was Alyeska Investment Group, an estimated $2.92M added.
- The largest Gritstone bio, Inc. Common Stock seller in Q2 2024 was Point72 Asset Management, an estimated $7.9M sold.
Based on aggregated 13F filings for Q2 2024.